NPI: 1124449533 · LINCOLN, NE 68516 · Family Nurse Practitioner · NPI assigned 01/02/2014
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 01/02/2014 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 931 | $8K |
| 2021 | 8,767 | $81K |
| 2022 | 4,311 | $22K |
| 2023 | 1,524 | $6K |
| 2024 | 121 | $0.00 |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7,989 | 6,267 | $53K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4,137 | 3,295 | $51K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 164 | 134 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 183 | 150 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 339 | 279 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 36 | 24 | $881.14 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21 | 14 | $504.20 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12 | 12 | $417.57 |
| 1159F | 683 | 598 | $0.08 | |
| 3074F | 556 | 506 | $0.02 | |
| 1160F | 494 | 435 | $0.02 | |
| 3078F | 431 | 389 | $0.01 | |
| 1036F | 467 | 423 | $0.00 | |
| 3008F | 142 | 125 | $0.00 |